This Act may be cited as the Second Chance for Moms Act of 2025.

(a) Warning label (1) In general Section 502 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352U.S. Code — Title 21, Section 352View official source on GovInfo) is amended by adding at the end the following: (hh) If it is the drug mifepristone, and its labeling does not bear the following statement printed in conspicuous text: WARNING: Medical evidence suggests that the abortifacient effects of mifepristone can be counteracted by natural progesterone, which can increase the chance of fetal survival. The American Society for Reproductive Medicine has determined that natural progesterone is safe in the first trimester of pregnancy. For more information, call [___]. (with the blank filled in to refer to the appropriate number for the hotline under section 1009 of the Public Health Service Act).. (2) Effective date Section 502(hh) of the Federal Food, Drug, and Cosmetic Act (as added by paragraph (1)) applies beginning on the date that is 6 months after the date of enactment of this Act. (b) Hotline Title X of the Public Health Service Act (42 U.S.C. 300 et seq.U.S. Code — Title 42, Section 300 and followingView official source on GovInfo) is amended by adding at the end the following: 1009. Hotline for reversal of effects of mifepristone (a) In general The Secretary shall establish or maintain, directly or by grant or contract, a toll-free hotline to provide support for 24 hours a day, 7 days a week, for women seeking to reverse the effects of the drug mifepristone. (b) Referrals to APR providers only A referral through the hotline described in subsection (a) may only be made to a health care provider that provides abortion pill reversal services..